
Microbiota Med sp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Microbiota Med is a company focused on researching and utilizing the health potential of microbiota. It offers services in designing research projects related to the impact of food, dietary supplements, and other orally administered xenobiotics on gut microbiota, as well as testing cosmetics. The company was established as a spin-off to implement and commercialize research findings in this field.
Financials
Revenue history
From the notes
| Profit allocation | Dividend and reserves | |
| Revenue structure | Sprzedaż usług |
Filing timeliness
Financial statements were filed on time, on average 53 days early.
- 202523/06/2026
- 202404/06/2025
- 202321/05/2024
- 202205/06/2023
- 202131/03/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Microbiota research
- Scientific research
- Development works
- Scientific consulting
- Cosmetics
- Postbiotics
Websites
- microbiota-med.comMikrobiota MedNginx
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jakub Patryk Piwowarski age 41 | 95 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 26, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $48,371$48,371 | BTM Innovations sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Empeko S.A. | $13,339.66 | empeko.pl | ||
| Thesybin Labs P.S.A. | $8,297.34 | thesybin.pl | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnością sp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Bioinfobank Capital sp. z o.o. | $6,252.45 | bioinfo.pl | ||
| Purevidence sp. z o.o. | $4,997.49 | purevidence.pl | ||
| Spinbionic sp. z o.o. | $3,516.36 | spinbionic.com | ||
| Omniseptica sp. z o.o. | $3,475.29 | omniseptica.com | ||
| Refoldit sp. z o.o. | $2,586.64 | refoldit.com | ||
| Passio Human Microbiome sp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| Microanalysis sp. z o.o. | $1,425.98 | microanalysis.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-11-04 | Address change (Ul. Grójecka 43/1a, 02-031, Warszawa → Ul. Grójecka 78/Lu-33, 02-359, Warszawa) | |
| 2022-12-20 | Address change (Ul. Franciszka Barcza 58/U18, 10-685, Olsztyn → Ul. Grójecka 43/1a, 02-031, Warszawa) | |
| 2021-02-24 | Entered in the register |
FAQ
Last updated: 2026-11-04
